Literature DB >> 24446182

Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a Russian population: a case-control study.

Anton G Kutikhin1, Arseniy E Yuzhalin, Alexey N Volkov, Alexey S Zhivotovskiy, Elena B Brusina.   

Abstract

In the last decade, a growing interest has been devoted to the evaluation of the impact of single nucleotide polymorphisms (SNP) on cancer risk. According to the results of multiple studies, among the genes that have a considerable influence on cancer risk are those encoding pattern recognition receptors, cytokines, and antioxidant defense enzymes. Nonetheless, the effect of numerous SNPs within these genes on cancer risk has been scarcely investigated. A case-control study of 401 cases and 300 sex- and age-matched controls was performed in order to explore the role of IL1B_1473G/C (rs1143623), SOD1_7958A/G (rs4998557), TLR4_1196C/T (rs4986791), IL10_1082A/G (rs1800896), IL17A_197G/A (rs2275913), and TLR4_896A/G (rs4986790) polymorphisms in the susceptibility to colorectal cancer (n = 244), gastric carcinoma (n = 72), and ovarian cancer (n = 85). The analysis revealed a significant relationship between the presence of heterozygous genotypes for IL1B_1473G/C and TLR4_896A/G polymorphisms and higher risk of rectal cancer (codominant model, OR = 1.67; 95% CI, 1.06-2.63; p = 0.048 and OR = 2.25; 95% CI, 1.26-4.02; p = 0.014, respectively). In addition, the variant G/G genotype of the IL10_1082A/G SNP was associated with a 2.5-fold increase in ovarian cancer risk with a borderline significance (codominant model, OR = 2.45; 95% CI, 1.14-5.25; p = 0.069). Similarly, the carriers of the C/T genotype for the TLR4_1196C/T polymorphism were more susceptible to rectal cancer with a borderline significance (codominant model, OR = 1.42; 95% CI, 0.80-2.51 p = 0.06). No statistically significant associations were found when stratifying the sample by subgroups of age, sex, and clinicopathological characteristics. Finally, we observed six combinations of haplotypes for the examined SNPs, each of which either profoundly increased or decreased cancer risk. The results from our study provided evidence that IL1B_1473G/C and TLR4_896A/G SNPs are implicated in rectal cancer development in a Russian population. Further research should be addressed to clarify the role of the abovementioned polymorphisms in cancer etiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24446182     DOI: 10.1007/s13277-014-1633-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

Review 1.  Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.

Authors:  Issam Zineh; Shiew-Mei Huang
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

2.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

3.  Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.

Authors:  Jing He; Li-Xin Qiu; Meng-Yun Wang; Rui-Xi Hua; Ruo-Xin Zhang; Hong-Ping Yu; Ya-Nong Wang; Meng-Hong Sun; Xiao-Yan Zhou; Ya-Jun Yang; Jiu-Cun Wang; Li Jin; Qing-Yi Wei; Jin Li
Journal:  Hum Genet       Date:  2012-02-28       Impact factor: 4.132

4.  Polymorphic mutations of the Mn-SOD gene in intact human lymphocytes and oral squamous cell carcinoma cell lines.

Authors:  Takaaki Kamatani; Tetsuya Yamamoto; Kazunori Yoneda; Tokio Osaki
Journal:  Biochem Cell Biol       Date:  2003-02       Impact factor: 3.626

Review 5.  Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis.

Authors:  Bárbara Peleteiro; Nuno Lunet; Carla Carrilho; Cecília Durães; José Carlos Machado; Carlo La Vecchia; Henrique Barros
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

Review 6.  Interleukin-12: clinical usage and molecular markers of cancer susceptibility.

Authors:  Arseniy E Yuzhalin; Anton G Kutikhin
Journal:  Growth Factors       Date:  2012-04-19       Impact factor: 2.511

Review 7.  Interleukin-10: new perspectives on an old cytokine.

Authors:  David M Mosser; Xia Zhang
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

8.  Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy.

Authors:  Abhilasha Agarwal; Usha Agrawal; Saurabh Verma; Nayan Kumar Mohanty; Sunita Saxena
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

9.  SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS.

Authors:  Pamela Milani; Stella Gagliardi; Emanuela Cova; Cristina Cereda
Journal:  Neurol Res Int       Date:  2011-04-17

Review 10.  Tumour necrosis factor gene polymorphism and disease prevalence.

Authors:  T Qidwai; F Khan
Journal:  Scand J Immunol       Date:  2011-12       Impact factor: 3.487

View more
  17 in total

Review 1.  Genetics and gastric cancer susceptibility.

Authors:  Yan Lu; Fang Lu; Sha Zeng; Suqing Sun; Li Lu; Lifeng Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.

Authors:  Lin Guo; Jin-Lei Ou; Tong Zhang; Liang Ma; Long-Fei Qu
Journal:  Tumour Biol       Date:  2015-06-12

3.  Cytokine Gene Polymorphisms Associated With Various Domains of Quality of Life in Women With Breast Cancer.

Authors:  Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-09-23       Impact factor: 3.612

Review 4.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

5.  Association Between the Interleukin-17 Gene Polymorphism -197G>A and the Risk of Prostate Cancer in a Galician Population.

Authors:  N Aguín; A Rodríguez-Alonso; N López-Trigo; I P Castuera; J R Luis; B Caeiro
Journal:  Pathol Oncol Res       Date:  2018-11-16       Impact factor: 3.201

6.  Genetic polymorphisms of IL-17A rs2275913, rs3748067 and IL-17F rs763780 in gastric cancer risk: evidence from 8124 cases and 9873 controls.

Authors:  Rami M Elshazli; Doaa O Salman; Maha M Kamel; Eman A Toraih; Manal S Fawzy
Journal:  Mol Biol Rep       Date:  2018-06-02       Impact factor: 2.316

7.  Polymorphisms in NFKB1 and TLR4 and interaction with dietary and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.

Authors:  Tine Iskov Kopp; Vibeke Andersen; Anne Tjonneland; Ulla Vogel
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

8.  Association between TLR4 (+896A/G and +1196C/T) polymorphisms and gastric cancer risk: an updated meta-analysis.

Authors:  Quan Zhou; Chenchen Wang; Xiaofeng Wang; Xiongyan Wu; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 9.  Toll-like receptor 4 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review.

Authors:  Wang Yan Sheng; Zhang Yong; Zhu Yun; Hu Hong; Luo Lin Hai
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

Review 10.  Multiple roles of toll-like receptor 4 in colorectal cancer.

Authors:  Dhanusha Yesudhas; Vijayakumar Gosu; Muhammad Ayaz Anwar; Sangdun Choi
Journal:  Front Immunol       Date:  2014-07-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.